(Q22242641)

1 August 2017

1 reference

title

Adverse consequences of lysergic acid diethylamide (English)

1 reference

lysergic acid diethylamide

1 August 2017

main subject

1 reference

HENRY DAVID ABRAHAM

1

0 references

ANDREW M. ALDRIDGE

series ordinal

2

0 references

Abraham HD

series ordinal

1

1 reference

1 August 2017

Aldridge AM

series ordinal

2

1 reference

1 August 2017

language of work or name

English

0 references

publication date

October 1993

0 references

1 October 1993

1 reference

1 August 2017

2 references

1 August 2017

volume

88

1 reference

1 August 2017

issue

10

1 reference

1 August 2017

page(s)

1327-1334

1 reference

Cross tolerance between LSD and psilocybin

1 August 2017

cites work

2 references

https://api.crossref.org/works/10.1111/J.1360-0443.1993.TB02018.X

20 April 2017

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions

21 January 2018

2 references

https://api.crossref.org/works/10.1111/J.1360-0443.1993.TB02018.X

20 April 2017

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

21 January 2018

Drug-induced psychosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Multiple drug abuse involving nonopiate, nonalcoholic substances. II. Physical damage, long-term psychological effects and treatment approaches and success

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Acute psychosis induced by psychotomimetic drug abuse. II. Neurochemical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Psychoses precipitated by psychotomimetic drugs. A follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Non-random relation between drugs of abuse and psychiatric diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

PERSISTENT HALLUCINOSIS FOLLOWING REPEATED ADMINISTRATION OF HALLUCINOGENIC DRUGS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Further Observations on Untoward Reactions to LSD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Visual Phenomenology of the LSD Flashback

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Visual function in past users of LSD: psychophysical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Long-lasting alterations in behavior and brain neurochemistry following continuous low-level LSD administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

LSD has high efficacy relative to serotonin in enhancing the cationic current Ih: intracellular studies in rat facial motoneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

Prolonged adverse reactions to LSD in psychotic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Acute psychosis induced by psychotomimetic drug abuse. I. Clinical findings

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Subtypes of drug abuse with psychosis. Demographic characteristics, clinical features, and family history

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Serotonin (5-HT) induces IPSPs in pyramidal layer cells of rat piriform cortex: evidence for the involvement of a 5-HT2-activated interneuron

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

1 reference

7 January 2021

Hallucinogenic drugs as precipitants of schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Development of psychiatric illness in drug abusers. Possible role of drug preference

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Confirmation of LSD intoxication by analysis of serum and urine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Use of haloperidol to reduce LSD flashbacks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Psychotherapy with lysergic acid diethylamide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Lysergic acid diethylamide: side effects and complications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

LSD-TREATMENT. EXPERIENCE GAINED WITHIN A THREE-YEAR-PERIOD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Drug-induced psychoses and schizophrenic reactions: a critical comparison.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Flashbacks: Recurrent Intrusive Images After the Use of LSD

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

A chronic impairment of colour vision in users of LSD

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1360-0443.1993.TB02018.X

7 January 2021

10.1111/J.1360-0443.1993.TB02018.X

Identifiers

DOI

1 reference

1 August 2017

1 reference